You are currently viewing a new version of our website. To view the old version click .
  • 1.7Impact Factor
  • Indexed inScopus
  • 33 daysTime to First Decision

Dermatopathology

Dermatopathology is an international, peer-reviewed, open access journal on dermatopathology, published quarterly online.
It is the official journal of the European Society of Dermatopathology (ESDP).
Indexed in PubMed | Quartile Ranking JCR - Q3 (Dermatology)

All Articles (243)

The Need for Standardization of PRAME Immunohistochemistry in Melanocytic Neoplasms

  • Calla M. Sullivan,
  • Dominick DiMaio and
  • Scott Lauer
  • + 4 authors

Accurate diagnosis of melanomas is crucial for proper evaluation and treatment. One immunohistochemical stain frequently utilized is PRAME (PReferentially expressed Antigen in MElanoma), a tumor-associated antigen expressed in most melanomas. This study aims to evaluate the reproducibility of PRAME scoring performed by dermatopathologists at an academic tertiary referral medical center. A blinded survey was designed featuring 21 melanocytic neoplasms stained with PRAME and H&E. For each case, five dermatopathologists provided a PRAME score from 0–4+, percent PRAME positivity, values for H-score, and a descriptive interpretation. Absolute agreement across raters was assessed using a Kappa statistic for PRAME score and intraclass correlations (ICCs) for H-score and PRAME percentage. Statistical analysis indicated poor inter-rater reliability for PRAME score (Kappa = 0.16), percent PRAME positivity (ICC = 0.31), and H-score (ICC = 0.40). Reporting language varied among pathologists. Our study demonstrated that the interpretation of PRAME immunohistochemistry lacks reproducibility, especially for challenging lesions. This suggests that a more rigorous, defined, and reproducible scoring method should be investigated for equivocal cases. Future studies may explore the utility of artificial intelligence software in the interpretation of PRAME for borderline lesions to improve reliability and standardize scoring.

31 December 2025

Melanoma samples stained with PRAME (PReferentially expressed Antigen in MElanom) demonstrating weak variable staining patterns despite strong positive controls. Magnification of 10× in panels (a,b), ~20× in panel (c), and ~40× in panel (d).
  • Case Report
  • Open Access

Reticulated acanthoma with sebaceous differentiation (RASD) is a rare, benign cutaneous neoplasm. Its variable clinical presentation frequently mimics both benign and malignant entities, posing a significant diagnostic challenge. We report a case of pigmented RASD in a 78-year-old Malay male of Fitzpatrick skin type IV who presented with a 5-year history of an 8 × 5 mm deeply pigmented, asymmetrical nodule on the left upper back, with a 2 mm central raised area showing less pigmentation. The lesion was clinically suspicious for malignant melanoma. Histopathological examination revealed characteristic features of RASD: a broad, plate-like, reticulated and pigmented epidermal proliferation with clusters of mature sebocytes at the bases of anastomosing rete ridges. Following biopsy confirmation, the residual lesion is being managed conservatively with observation. This case demonstrates an unusual heavily pigmented clinical presentation that completely obscured the typical yellowish hue associated with sebaceous differentiation, highlighting pigmented RASD as an important diagnostic pitfall in patients with skin of color. In conclusion, RASD should be included in the differential diagnosis of pigmented cutaneous lesions, especially in patients with skin of color. Recognition of this benign entity can prevent unnecessary aggressive surgical intervention.

30 December 2025

Clinical photograph of reticulated acanthoma with sebaceous differentiation. A well-demarcated, asymmetrical, deeply pigmented nodule (8 × 5 mm) on the left upper back. The lesion displays dark gray to blue-black coloration with a central raised area (2 mm) showing less pigmentation, surrounded by a deeply pigmented rim. This was concerning clinically for malignant melanoma. Note the complete absence of the yellowish hue typically associated with sebaceous neoplasms.

Abductive reasoning, or abduction, is a key process in scientific discovery and medical diagnosis. In everyday dermatology and dermatopathology, however, it functions as the practical engine behind differential diagnosis, clinicopathologic correlation, and disciplined pattern recognition. In this paper, we retain the epistemological foundation of abduction but translate it into usable steps for clinicians and dermatopathologists. We distinguish abduction from deduction and induction; separate creative abduction (which generates new concepts) from selective abduction (daily diagnostic choice); and show how both operate within a simple Select-and-Test (ST) Model: select a hypothesis, deduce what else should be true, test against data, and then update. We then reinterpret Ackerman’s algorithmic method of pattern analysis as an operationalization of the ST-Model. Through a couple of concise case vignettes, we illustrate visual and manipulative abduction, nonmonotonic updates, and the role of artifacts (dermoscopy, DIF, stains) as so-called epistemic mediators. Finally, we map contemporary AI tools to selective abduction and propose practical guardrails for fairness, transparency, and accountability. The result is a pragmatic framework that preserves philosophical depth while addressing the daily needs of dermatologists and dermatopathologists in the clinic and at the microscope.

25 December 2025

Creative and selective abduction.

Increased Expression of Angiopoietin 2 and Tie2 in Rosacea

  • Aysin Kaya,
  • Jean-Hilaire Saurat and
  • Nathalie Satta
  • + 1 author

In this study we evaluated the expression of Angiopoietin 1, Angiopoietin 2, and Tie2 by immunohistochemistry in the skin of 10 patients with erythemato telangiectatic and papulopustular rosacea. Significantly increased expression of Tie2 and Angiopoietin 2 in the endothelial cells of the dermal vessels in rosacea skin vs. non-lesional skin (100% and 33.3% for Tie2, and 100% and 50% for Angiopoietin 2) was observed. There was no difference in the expression of Angiopoietin 1 and phosphorylated Tie2 (pTie2) between the lesional skin of rosacea and non-lesional skin.

25 December 2025

Angiopoietin 1 (Ang1), Angiopoietin 2 (Ang2), Tie2, and pTie2 stainings in rosacea skin. Skin biopsy of a rosacea patient with papulopustular lesions shows subcorneal/intraepidermal collections of neutrophils realizing pustules, ectatic dermal vessels, and perivascular and perifollicular inflammatory infiltrate of lymphocytes and histiocytes ((A), hematoxylin eosin staining, original magnification, 2×). Dermal vessels show an increased immunostaining for Angiopoietin 2 ((C), original magnification, 6.5× and (E), original magnification, 26×) and Tie2 ((F), original magnification, 6.5× and (H), original magnification, 26×), when compared with the immunostainings for Angiopoietin 1 ((B), original magnification, 6.5× and (D), original magnification, 26×) and pTie2 ((G), original magnification, 6.5× and (I), original magnification, 26×). The evaluation of immunostaining was performed in a blinded fashion using a scoring system of 0–3 according to the intensity of staining (0: no staining, 1+: slight staining, 2+: moderate staining, 3+: strong staining) after the examination of 3 microscopic fields per subject by a board-certified dermatopathologist (GK).

News & Conferences

Issues

Open for Submission

Editor's Choice

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Dermatopathology - ISSN 2296-3529